Psychemedics Corp
NASDAQ:PMD
Psychemedics Corp
Accounts Receivables
Psychemedics Corp
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Psychemedics Corp
NASDAQ:PMD
|
Accounts Receivables
$3.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
DaVita Inc
NYSE:DVA
|
Accounts Receivables
$2.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Accounts Receivables
$10.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
2%
|
|
Cigna Corp
NYSE:CI
|
Accounts Receivables
$20.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accounts Receivables
$2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
See Also
What is Psychemedics Corp's Accounts Receivables?
Accounts Receivables
3.7m
USD
Based on the financial report for Dec 31, 2023, Psychemedics Corp's Accounts Receivables amounts to 3.7m USD.
What is Psychemedics Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-2%
Over the last year, the Accounts Receivables growth was -1%. The average annual Accounts Receivables growth rates for Psychemedics Corp have been 3% over the past three years , -5% over the past five years , and -2% over the past ten years .